Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-038777

VP Clinical Reg Affairs bought 500 shares at $8.57 ($4,285)

From the SEC's structured data for this filing

Trades in this filing

Thompson Jaye · VP Clinical Reg Affairs

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-27 Purchase : show line 1 in the form +500 $8.57 $4,285 260,348 D
Open-market purchases · 500 sh · avg $8.57 · $4,285
Loading xslF345X05/ownership.xml…